Adco Nebrafen inhalant Solution

    Adco Nebrafen inhalant Solution

    S3


    1. What ADCO NEBRAFEN is and what it is used for

    The active ingredients fenoterol hydrobromide and ipratropium bromide both belong to the group of medicines known as bronchodilators. ADCO NEBRAFEN is used to open up the airways to make breathing easier for patients with bronchial asthma, chronic bronchitis and emphysema (all lung disorders) and any condition that obstructs the airways. This medicine is for inhalation only.

    2. What you need to know before you use ADCO NEBRAFEN

    Do not use ADCO NEBRAFEN:

    • If you are hypersensitive (allergic) to fenoterol hydrobromide and/or ipratropium bromide or any of the other ingredients of ADCO NEBRAFEN (listed in section 6)
    • If you have hypertrophic obstructive cardiomyopathy and tachyarrhythmia (heart conditions)
    • If you are about to give birth due to the uterine relaxant effect of fenoterol
    • If you are under the age of 18 years.

    Warnings and precautions

    Special care should be taken with ADCO NEBRAFEN and your doctor informed if you have:

    • Diabetes (high blood sugar levels)
    • Any heart disorders or conditions
    • High blood pressure
    • Glaucoma (pressure in the eye)
    • An enlarged prostate
    • Urinary retention (difficulty emptying your bladder)
    • Any type of bowel or intestine obstruction or inflammation
    • Diarrhoea and/or fever
    • Down’s syndrome or albinism
    • Parkinsonism.

    It is important not to exceed the maximum dose. High doses may increase the risk of serious side effects affecting your heart. The risk is further increased if you are taking other medicines that cause low potassium levels and an abnormal heartbeat, or if you have low oxygen levels or have too much acid in your body. Ensure you have been instructed on the correct administration of ADCO NEBRAFEN inhalation solution. Care must be taken not to allow the solution or mist to enter into the eyes. It is recommended that the nebulised solution be administered via a mouth piece. If this is not available and a nebuliser mask is used, it must fit properly. If the solution or mist does enter your eyes, it may cause certain eye conditions and symptoms. If this does happen, consult your doctor.

    Children and adolescents

    Do not use this medicine if you are under the age of 18 years.

    Other medicines and ADCO NEBRAFEN

    Always tell your health care provider if you are taking any other medicine. (This includes all complementary or traditional medicines.)

    In particular, tell your doctor, pharmacist or health care provider if you are taking any other medicine:

    • Used to open up the airways to make breathing easier,
    • Used for asthma or any lung conditions
    • Used for depression.

    Pregnancy and breastfeeding

    If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, please consult your doctor, pharmacist or other health care provider for advice before taking this medicine. Do not use this medicine if you are pregnant or breastfeeding.

    Driving and using machines

    It is not always possible to predict to what extent ADCO NEBRAFEN may interfere with your daily activities. You should ensure that you do not engage in activities requiring mental alertness, judgement and/or sound coordination and vision e.g. driving, riding, flying, sailing or operating machines/equipment until you are aware of the measure to which ADCO NEBRAFEN affects you.

    3. How to use ADCO NEBRAFEN

    Do not share medicines prescribed for you with any other person. For oral inhalation only, administered via a ventilator or a nebuliser. The solution is ready for use and requires no dilution. Always use ADCO NEBRAFEN exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

    The usual dose for adults is:

    Treatment of attacks:

    If you are experiencing an attack of difficult breathing, use one ampoule of ADCO NEBRAFEN. This should be sufficient for prompt symptom relief in most cases. If in very severe cases, two unit dose vials are required for symptom relief, this should be administered under medical supervision.

    Long-term treatment:

    One ampoule of ADCO NEBRAFEN three to four times daily. On demand treatment (symptom oriented) is preferable to regular use. DO NOT EXCEED THE RECOMMENDED DOSE.

    Instructions for use:

    1. Prepare the nebuliser for filling, according to the instructions provided by the manufacturer or your doctor.
    2. Remove one ampoule by detaching from the adjacent one.
    3. Flick the top of the ampoule to dispel any fluid in the neck.
    4. Detach top portion by twisting.
    5. Squeeze the contents of the ampoule into the reservoir of the nebuliser.
    6. Assemble the nebuliser and use as directed. After use throw away any solution left in the reservoir and clean the nebuliser, following the manufacturer's instructions.

    Since the ampoules do not contain a preservative, it is important that the contents of each ampoule are used up immediately after opening and that a fresh ampoule is used for each administration to avoid microbial contamination. Partly used, opened or damaged ampoules should be discarded.

    Your doctor will tell you how long your treatment with ADCO NEBRAFEN will last. If you have the impression that the effect of ADCO NEBRAFEN is too strong or too weak, tell your doctor or pharmacist.

    If you use more ADCO NEBRAFEN than you should

    In the event of overdosage, consult your doctor or pharmacist. If neither is available, contact the nearest hospital or poison centre. Symptoms of overdosage include: Feeling hot, trembling or shaking, nausea, restlessness, fast heartbeat, dizziness, headache and a feeling of pressure in the chest.

    4. Possible side effects

    ADCO NEBRAFEN can have side effects. Not all side effects reported for ADCO NEBRAFEN are included in this leaflet. Should your general health worsen or if you experience any untoward effects while taking ADCO NEBRAFEN, please consult your health care provider for advice.

    If any of the following happens, stop using ADCO NEBRAFEN and tell your doctor immediately or go to the casualty department at your nearest hospital:

    • Hypersensitivity reactions: swelling of the hands, feet, ankles, face, lips and mouth or throat, which may cause difficulty in swallowing or breathing; rash or itching; fainting.
    • Tremor, shaking or restlessness
    • Difficulty seeing or sensitivity to light
    • Changes in the way your heart beats, for example, if you notice it beating faster.

    These are all serious side effects. If you have them, you may have had a serious reaction to ADCO NEBRAFEN. You may need urgent medical attention or hospitalisation.

    Tell your doctor if you notice any of the following:

    • Muscle cramps and tension
    • Dizziness
    • Fatigue
    • Sweating
    • Headache
    • Dryness of the mouth and difficulty swallowing
    • Thirst
    • Dryness of the skin
    • Throat irritation
    • Cough
    • Difficulty urinating
    • Constipation

    If you notice any side effects not mentioned in this leaflet, please inform your doctor or pharmacist.

    Reporting of side effects

    If you get side effects, talk to your doctor, pharmacist or nurse. You can also report side effects to SAHPRA via the Med Safety APP (Medsafety X SAHPRA) and eReporting platform (who - umc - org) found on SAHPRA website. By reporting side effects, you can help provide more information on the safety of ADCO NEBRAFEN.

    For reporting of side effects directly to the Holder of the Certificate of Registration, contact +27 11 635 0134 or email [email protected]

    5. How to store ADCO NEBRAFEN

    Store the ampoules in the outer packaging, at or below 25 °C, until required for use. Protect from light. Store all medicines out of reach of children. Return all unused medicine to your pharmacist. Do not dispose of unused medicine in drains or sewerage systems (e.g. toilets).

    Important Disclaimer

    The Adco Nebrafen inhalant Solution professional information leaflet below is the property of Adcock Ingram Critical Care and is provided on Somayeza exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Somayeza serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Unlock Exclusive Features

    To ensure the fastest, most secure experience, this feature is exclusively available on the free Somayeza mobile app.

    Download the App to Unlock
    On This Page
    Adco Nebrafen inhalant Solution
    1/-
    Official PDF leaflet

    The patient information text is available above. Load the original PDF only when you need it.

    Somayeza AI
    Hello! I am your medical reading assistant. What would you like to know about this patient information leaflet?
    Successfully Stashed! 💊

    This patient information leaflet has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites